Table 5. Multivariate analysis comparing patients with early onset psoriasis and childhood onset psoriasis.
| P-value | OR (95%CI) | |
|---|---|---|
| NAFLD | ||
| Age | 0.000 | 1.052(1.024–1.081) |
| Sex | NS | |
| Age at onset (EOP vs COP)a | 0.000 | 0.058(0.020–0.170) |
| Metabolic syndrome | 0.004 | 0.244(0.093–0.640) |
| Hypertriglyceridemia | ||
| Age | NS | |
| Sex | NS | |
| Age at onset (EOP vs COP)a | 0.007 | 0.177(0.050–0.627) |
| Age | NS | |
| Sex | 0.064 | |
| Age at onset (EOP vs COP)a | 0.087 | |
| Diabetes | ||
| Age | NS | |
| Sex | NS | |
| Age at onset (EOP vs COP)a | NS | |
| Hyperuricemia | ||
| Age | NS | |
| Sex | 0.024 | 0.184(0.042–0.803) |
| Age at onset (EOP vs COP)a | NS | |
| Metabolic syndrome | NS |
OR, odds ratio; CI, confidence interval. NAFLD, nonalcoholic fatty liver disease.
a: early onset psoriasis (EOP), childhood onset psoriasis (COP). NS, not significant